A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2004
10/12/2004	US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/12/2004	US6803362 Heterocyclic compounds
10/12/2004	US6803234 Expression vector for use in the transduction of human chondrocyte; obtain chondrocytes, incubate with expression vector, monitor cell for expression of reporter molecule
10/12/2004	US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties
10/12/2004	US6803211 Cancer therapy
10/07/2004	WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis
10/07/2004	WO2004085452A1 Compound having affinity with calcified tissue
10/07/2004	WO2004085448A2 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
10/07/2004	WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
10/07/2004	WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004	WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	WO2004069999A3 Screening method
10/07/2004	WO2004067568A3 Human il-1 beta antagonists
10/07/2004	WO2004067027A9 Osteogenic composition
10/07/2004	WO2004054514A3 C-6 modified indazolylpyrrolotriazines
10/07/2004	WO2004048386A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS
10/07/2004	WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004	WO2003049679A3 Mitotic kinesin inhibitors
10/07/2004	WO2002092000A3 Hbm variants that modulate bone mass and lipid levels
10/07/2004	WO2002088317A3 Fusion molecules and methods for treatment of immune diseases
10/07/2004	US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004	US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders
10/07/2004	US20040198978 for treating autoimmune diseases selected from psoriasis, multiple sclerosis and rheumatoid arthritis; N-(3-oxoundecanoyl)-L-homoserine lactone (OuDHL) and 2-n-heptyl-3-hydroxy-4(1H)-quinolone for example
10/07/2004	US20040198832 Compositions and methods for treating amyloidosis
10/07/2004	US20040198831 Remedial agent for arthrosis deformans
10/07/2004	US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects
10/07/2004	US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004	US20040198801 Antiinflammatory agents; sepsis
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198771 medical equipment for angioplasty
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198737 Azaindoles
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198725 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
10/07/2004	US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004	US20040198716 Cysteine protease inhimbitors
10/07/2004	US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations
10/07/2004	US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
10/07/2004	US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy
10/07/2004	US20040198674 Compositions for preventing hormone induced adverse effects
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs
10/07/2004	US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin
10/07/2004	US20040197908 Using cartilage differentiation inducing broth, undifferentiated mesenchymal cells and ultrasonic pulsation to induce, differentiate and propagate bone tissue; treating bone disorders
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197429 Selective COX-2 inhibition from plant extracts
10/07/2004	US20040197399 N-fatty acid-amino acid conjugates and therapeutic uses
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/07/2004	US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/07/2004	US20040197329 Remedies or preventives for rheumatoid arthritis
10/07/2004	DE10311889A1 Zellpräparat und Verwendung des Präparats zur Behandlung von Gelenken und Knorpeldefekten, sowie Verfahren zur Herstellung Cell preparation and use of the preparation for the treatment of joints and cartilage defects, and methods for preparing
10/07/2004	CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	CA2520147A1 Compound having affinity with calcified tissue
10/06/2004	EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp
10/06/2004	EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463800A2 Chondrocyte precursors derived from human embryonic stem cells
10/06/2004	EP1463758A2 Mammal prolactin variants
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463751A2 Albumin fusion proteins
10/06/2004	EP1463742A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1150569A4 Method for reducing hip joint laxity
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004	EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004	CN1535153A Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/06/2004	CN1535152A Use of bisphosphonates for pain treatment
10/06/2004	CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004	CN1533801A Golden hairpin dendrobium extract and its medicinal composition
10/06/2004	CN1533793A Medicine for treating omitis, arthritis
10/06/2004	CN1533786A Blood quickening statis transforming plaster
10/06/2004	CN1169959C Polypeptide variants with raised heparin-binding capacity
10/06/2004	CN1169829C Non-T cell conjugating peptide and its use
10/06/2004	CN1169788C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
10/06/2004	CN1169768C (4-alkynyl), aromatic keto-acid compound, synthesis method and its application
10/06/2004	CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage
10/06/2004	CN1169563C Strengthening-bone bills contg. cortex Eucommiae for treating RD
10/06/2004	CN1169562C External use ointment for restoring period of knocks and falls
10/06/2004	CN1169559C Medical Liquor for treating rheuamtic arthritis ischias, etc
10/06/2004	CN1169557C Chinese medicine for treating gout and process preparing it
10/06/2004	CN1169553C Medicinal wine for curing rheumatism rheumatoid and various diseases caused by wind and cold
10/06/2004	CN1169548C Chinese medicine preparation for curing atrophic arthritis

1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 820